Ranbaxy Sues FDA Over Revoked Generic Approvals

Ranbaxy Laboratories has sued the U.S. FDA for revoking approvals granted to launch generic copies of AstraZeneca's Nexium and Roche's Valcyte.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news